Cargando…
Application Of Adoptive Immunotherapy In Ovarian Cancer
Ovarian cancer (OC) has been the most fatal gynecological disease that threatens women’s health. Surgery and platinum-based chemotherapy are the basic ovarian cancer treatments that can improve survival, but the five-year survival rate has not improved because of delayed diagnosis, drug resistance,...
Autores principales: | Yang, Siyu, Yin, Xiaojiao, Yue, Ying, Wang, Siqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775498/ https://www.ncbi.nlm.nih.gov/pubmed/31632055 http://dx.doi.org/10.2147/OTT.S221773 |
Ejemplares similares
-
Adoptive immunotherapy against ovarian cancer
por: Mittica, Gloria, et al.
Publicado: (2016) -
Adoptive Cell Transfer: Is it a Promising Immunotherapy for Colorectal Cancer?
por: Fan, Jiaqiao, et al.
Publicado: (2018) -
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
por: Yee, Cassian
Publicado: (2005) -
Immunotherapy in Ovarian Cancer
por: Siminiak, Natalia, et al.
Publicado: (2022) -
Adoptive T Cell Immunotherapy for Cancer
por: Perica, Karlo, et al.
Publicado: (2015)